When the 'Holiday Season' Is No Holiday at all for Those With ME/CFS
Is December getting to you? Jody Smith shares some thoughts on some of the struggles that all too often attend this time of year ...
Discuss the article on the Forums.

Medical journal in the US just eviscerated a drug that's cost taxpayers over $1 B 9/12/17 Flipboard

Discussion in 'Other Health News and Research' started by *GG*, Sep 16, 2017.

  1. *GG*

    *GG* senior member

    Concord, NH
    A new study published by JAMA Internal Medicine poses a really important question to lawmakers and taxpayers alike.

    Over the past five years, why has the US government spent $1 billion on a drug that is no more effective than alternatives that are tens of thousands of dollars cheaper per treatment?

    The drug is called Acthar, and for the past year it has been the focus of a study by the Oregon Health and Science University School of Medicine and Oregon State that has been trying to understand why doctors keep prescribing it for ailments it has never been proved to treat effectively.


  2. TrixieStix

    TrixieStix Senior Member

    This reminded me of the "Sunshine Act" government mandated website "Open Payments" we have here in the US where you can look up any doctor (physician assistants also) and see what payments they have received from pharmaceutical companies and when they received them. It's really easy to use.


    After you have searched the medical professionals name there is a tab on the screen to the right of the "Summary" that says "Payment Information". Click on "Payment Information" and it takes you to the details about what specific pharmaceutical company payments came from.
    *GG* and IThinkImTurningJapanese like this.

See more popular forum discussions.

Share This Page